Viaskin Placebo

BIOLOGICAL3 trials

Sponsors

DBV Technologies, Children's Hospital of Philadelphia

Conditions

Eosinophilic EsophagitisFood AllergyMilk AllergyPeanut Allergy

Phase 1

Efficacy and Safety of Viaskin Milk in Children With IgE-Mediated Cow's Milk Allergy

CompletedNCT02223182

DBV TechnologiesFood Allergy

Start: 2014-11-30End: 2020-12-22Updated: 2024-11-20

Phase 2

Efficacy and Safety of Several Doses of Viaskin Peanut in Adults and Children With Peanut Allergy

CompletedNCT01675882

DBV TechnologiesPeanut Allergy

Start: 2012-08-31End: 2014-07-31Updated: 2021-10-27

Milk Patch for Eosinophilic Esophagitis

CompletedNCT02579876

Children's Hospital of PhiladelphiaEosinophilic Esophagitis, Milk Allergy

Start: 2015-10-31End: 2018-11-20Updated: 2019-07-10

Related Papers

Varying Doses of Epicutaneous Immunotherapy With Viaskin Milk vs Placebo in Children With Cow’s Milk Allergy

JAMA Pediatrics2024-02-2614 citations

Efficacy of Epicutaneous Immunotherapy in Children With Milk-Induced Eosinophilic Esophagitis.

2019-05-1432 citations

Effect of Varying Doses of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Exposure Among Patients With Peanut Sensitivity

JAMA2017-11-14215 citations